Carmichael Hill & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.1K | Hold |
82
| – | – | ﹤0.01% | 511 |
|
|
2024
Q2 | $7.6K | Hold |
82
| – | – | ﹤0.01% | 505 |
|
|
2024
Q1 | $7.78K | Buy |
82
+51
| +165% | +$4.84K | ﹤0.01% | 505 |
|
|
2023
Q4 | $2.77K | Hold |
31
| – | – | ﹤0.01% | 581 |
|
|
2023
Q3 | $2.26K | Hold |
31
| – | – | ﹤0.01% | 586 |
|
|
2023
Q2 | $2.58K | Hold |
31
| – | – | ﹤0.01% | 585 |
|
|
2023
Q1 | $2.36K | Hold |
31
| – | – | ﹤0.01% | 592 |
|
|
2022
Q4 | $2.57K | Sell |
31
-534
| -95% | -$44.3K | ﹤0.01% | 561 |
|
|
2022
Q3 | $45K | Buy |
565
+145
| +35% | +$11.5K | 0.02% | 285 |
|
|
2022
Q2 | $31K | Sell |
420
-200
| -32% | -$14.8K | 0.02% | 330 |
|
|
2022
Q1 | $56K | Buy |
620
+298
| +93% | +$26.9K | 0.03% | 278 |
|
|
2021
Q4 | $36K | Hold |
322
| – | – | 0.02% | 335 |
|
|
2021
Q3 | $40K | Sell |
322
-49
| -13% | -$6.09K | 0.02% | 316 |
|
|
2021
Q2 | $50K | Hold |
371
| – | – | 0.03% | 280 |
|
|
2021
Q1 | $50K | Hold |
371
| – | – | 0.03% | 277 |
|
|
2020
Q4 | $52K | Hold |
371
| – | – | 0.03% | 257 |
|
|
2020
Q3 | $41K | Sell |
371
-10
| -3% | -$1.11K | 0.03% | 264 |
|
|
2020
Q2 | $43K | Buy |
381
+216
| +131% | +$24.4K | 0.03% | 248 |
|
|
2020
Q1 | $13K | Buy |
165
+40
| +32% | +$3.15K | 0.01% | 369 |
|
|
2019
Q4 | $12K | Buy |
+125
| New | +$12K | 0.01% | 407 |
|